RAPT Therapeutics, Inc.

NASDAQ:RAPT

11.38 (USD) • At close August 29, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 0000005.2880000.64100.8860.6410.7560.9660.8691.2221.3021.5281.2770.93500000000
Kosten van de omzet 0.20000.3050.3140.3230.9080.8530.8830.730.7280.70.6890.231000000000000000
Brutowinst -0.2000-0.305-0.3144.965-0.908-0.853-0.883-0.089-0.7280.186-0.0480.5250.9660.8691.2221.3021.5281.2770.93500000000
Brutowinstmarge 0000000.939000-0.13900.21-0.0750.694111111100000000
Onderzoek- en ontwikkelingskosten 12.3412.04246.45613.3422.6424.78126.76427.02221.64225.57419.45416.59914.35916.6714.29915.72513.1913.77110.90412.91210.98610.68310.198.5828.2677.878.389.1816.97.306
Algemene en administratieve kosten 7.1957.2238.0096.4486.697.7376.4536.8976.7225.9884.9775.0795.4364.7484.4913.7743.764.0123.4833.1972.8023.2892.6251.7332.6921.6741.2911.3641.4681.057
Verkoop- en marketingkosten 00000-0.314-0.32300000000000000000000000
Verkoop-, algemene en administratieve kosten 6.9957.2238.0096.4486.697.4236.136.8976.7225.9884.9775.0795.4364.7484.4913.7743.764.0123.4833.1972.8023.2892.6251.7332.6921.6741.2911.3641.4681.057
Overige kosten 00000002.5483.0842.2911.480.443-0.2750.3090.105-0.118-0.0290.0470000.13500000000
Bedrijfskosten 19.33519.26554.46519.78829.3332.20432.89433.91928.36431.56224.43121.67819.79521.41818.7919.49916.9517.78314.38716.10913.78813.97212.81510.31510.9599.5449.67110.5458.3688.363
Bedrijfsresultaat -19.535-19.265-54.465-19.788-29.33-32.518-33.217-33.919-28.364-31.562-24.431-21.678-18.909-20.777-18.034-18.533-16.081-16.561-13.085-14.581-12.511-13.037-12.815-10.315-10.959-9.544-9.671-10.545-8.368-8.363
Bedrijfsresultaat ratio 000000-6.282000-38.1140-21.342-32.413-23.854-19.185-18.505-13.552-10.05-9.543-9.797-13.94300000000
Totaal overige inkomsten en kosten netto 1.8922.11.2161.3561.6671.9972.3412.5483.0842.2911.480.443-0.2750.3090.105-0.118-0.0290.0470.5490.2370.3910.1350.2590.3440.3330.3560.2410.2610.1640.132
Inkomen voor belasting -17.643-17.165-53.249-18.432-27.663-30.521-30.876-31.371-25.28-29.271-22.951-21.235-19.184-20.468-17.929-18.651-16.11-16.514-12.536-14.344-12.12-12.902-12.556-9.971-10.626-9.188-9.43-10.284-8.204-8.231
Inkomen voor belasting ratio 000000-5.839000-35.8050-21.652-31.931-23.716-19.307-18.539-13.514-9.628-9.387-9.491-13.79900000000
Belastingkosten 000000.271000-2.291-1.48-0.4430.275-0.30900.0290.05600.1990.2870.2670.2370.660000000
Nettowinst -17.643-17.165-53.249-18.432-27.663-30.521-30.876-31.371-25.28-26.98-21.471-20.792-19.459-20.159-17.929-18.651-16.11-16.514-12.735-14.631-12.387-13.139-13.216-9.971-10.626-9.188-9.43-10.284-8.204-8.231
Nettowinstmarge 000000-5.839000-33.4960-21.963-31.449-23.716-19.307-18.539-13.514-9.781-9.575-9.7-14.05200000000
WPA (Winst Per Aandeel) -0.655-0.08-1.14-0.47-0.71-0.79-0.8-0.82-0.66-0.7-0.6-0.62-0.62-0.68-0.61-0.63-0.63-0.66-0.52-0.6-0.51-0.56-0.87-12.41-0.47-0.53-0.54-0.59-0.48-0.48
Verwaterde WPA -0.655-0.08-1.14-0.47-0.71-0.79-0.8-0.82-0.66-0.7-0.6-0.62-0.62-0.68-0.61-0.63-0.63-0.66-0.52-0.6-0.51-0.56-0.87-12.41-0.47-0.53-0.54-0.59-0.48-0.48
EBITDA -17.443-19.013-54.178-19.491-29.025-32.204-32.894-33.594-28.095-31.263-24.223-21.418-18.635-20.516-17.803-18.304-15.825-16.281-12.82-14.318-12.115-12.838-12.496-9.973-10.621-9.213-9.377-10.236-8.046-8.051
EBITDA ratio 000000-6.22000-37.7890-21.033-32.006-23.549-18.948-18.211-13.323-9.846-9.37-9.487-13.7300000000